FDA Adverse Event
Injury
Summary report: N
INFUSOR
MDR report key: 2981563
·
Received February 27, 2013
Report
- Report Number
- 1416980-2013-04855
- Event Type
- Injury
- Date Received
- February 27, 2013
- Date of Event
- February 4, 2013
- Report Date
- February 4, 2013
- Manufacturer
- BAXTER HEALTHCARE - IRVINE
- Product Code
- MEB
- PMA / PMN Number
- K071222
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- NURSE
Narratives
Additional Manufacturer Narrative · 1
(B)(4). A BATCH REVIEW HAS BEEN CONDUCTED WHICH REVEALED PRODUCT MET ALL OF THE ACCEPTANCE CRITERIA FOR RELEASE. THE PROBLEM WAS NOT CONFIRMED AND THE ASSIGNABLE CAUSE IS UNDETERMINED.
Additional Manufacturer Narrative · 1
(B)(4). THE SAMPLE IS NOT AVAILABLE FOR EVALUATION. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.
Description of Event or Problem · 1
IT WAS REPORTED THAT THE PATIENT WAS VOMITING DURING USE OF AN INFUSOR. THE PRODUCT WAS FLOWING FAST DURING THE INFUSION. THERE WERE 0.25% BUPIVACAINE 120ML, 50MG/ML FENTANYL 24ML AND NORMAL SALINE 96ML BEING USED. BAXTER IS IN THE PROCESS OF OBTAINING ADDITIONAL INFORMATION REGARDING THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 83847 | INFUSOR | PUMP, INFUSION, ELASTOMERIC | MEB | BAXTER HEALTHCARE - IRVINE | 12B082 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |